Skip to main content

Published locations for FDA approves topical ruxolitinib for nonsegmental vitiligo

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves topical ruxolitinib for nonsegmental vitiligo

User login

  • Reset your password
  • /content/fda-approves-topical-ruxolitinib-nonsegmental-vitiligo
  • /clinicianreviews/article/256364/pigmentation-disorders/fda-approves-topical-ruxolitinib-nonsegmental
  • /edermatologynews/article/256364/pigmentation-disorders/fda-approves-topical-ruxolitinib-nonsegmental
  • /familypracticenews/article/256364/pigmentation-disorders/fda-approves-topical-ruxolitinib
  • /internalmedicinenews/article/256364/pigmentation-disorders/fda-approves-topical-ruxolitinib
  • /internalmedicine/article/256364/pigmentation-disorders/fda-approves-topical-ruxolitinib-nonsegmental
  • /dermatology/article/256364/pigmentation-disorders/fda-approves-topical-ruxolitinib-nonsegmental
  • /familymedicine/article/256364/pigmentation-disorders/fda-approves-topical-ruxolitinib-nonsegmental